Literature DB >> 29961914

Comparative study of microRNA profiling in one Chinese Family with PSEN1 G378E mutation.

Zhanyun Lv1, Liangchen Hu1, Yan Yang1, Kui Zhang1, Zuzhen Sun1, Jing Zhang1, Lipan Zhang1, Yanlei Hao2.   

Abstract

MicroRNAs are not widely studied in familial Alzheimer's disease cases, whether the microRNA profilings in familial Alzheimer's disease patients are similar to the sporadic AD patients is not known. This study aims to investigate the differential expression of microRNAs (miRNAs) associated with early-onset familial Alzheimer's disease (EO-FAD) in a Chinese family. We performed the gene mutation analysis in a family clinically diagnosed of EO-FAD. Micro-arrays were used to profile the miRNAs in cerebrospinal fluid of 2 affected members, 2 unaffected carriers and 2 mutation negative controls. The clinical presentation confirmed the EO-FAD diagnosis, and a recurrent mutation of the PSEN1 p.G378E was found in the family. The result showed that in the miRNAs expression profile, a total of 166 miRNAs were up-regulated and 3 miRNAs were down-regulated in the affected individuals compared with mutation negative individuals. But after Benjamini Hochberg FDR correction, only 25 miRNAs were significantly up-regulated and no miRNA was down-regulated, the levels of miR-30a-5p, miR-4758-3p and let-7a-3p were elevated significantly. Compared with mutation negative controls, 21 miRNAs were up-regulated and 18 microRNAs were down-regulated in the unaffected mutation carriers, after Benjamini Hochberg FDR correction, miR-345-5p was up-regulated and miR-4795-3p was down-regulated in the unaffected mutation carriers. And there was no difference between the affected members and unaffected mutation carriers. GO database showed that the top biological processes affected by the predicted target genes are nucleic acid binding transcription factor activity and transcription factor activity (sequence-specific DNA binding) (GO:0001071 and GO:0003700). The result of KEGG pathways showed 64 pathways were implicated in the regulatory network. The present study identified the miRNA profiling of Chinese siblings with G378E mutation in the PSEN1. Compared with mutation negative controls, the levels of 25 miRNAs including miR-30a-5p, miR-4758-3p and let-7a-3p were elevated significantly in the affected members, miR-345-5p was up-regulated and miR-4795-3p was down-regulated in the unaffected mutation carriers. Our study showed the microRNA profilings in the cases of a EO-FAD family with PSEN1 p.G378E mutation, but because of the individuals in the family was small, the results in other types of EO-FAD still need further studied.

Entities:  

Keywords:  EO-FAD; FOXO signaling pathway; Let-7a-3p; miR-30-5p; miR-4758-3p; microRNA profiling

Mesh:

Substances:

Year:  2018        PMID: 29961914     DOI: 10.1007/s11011-018-0279-2

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  47 in total

1.  Missense mutation in exon 11 (Codon 378) of the presenilin-1 gene in a French family with early-onset Alzheimer's disease and transmission study by mismatch enhanced allele specific amplification. Mutations in brief no. 141. Online. besancon@rockefeller1.univ.lyon1.fr.

Authors:  R Besançon; A Lorenzi; M Cruts; S Radawiec; F Sturtz; E Broussolle; G Chazot; C van Broeckhoven; G Chamba; A Vandenberghe
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

2.  Novel mutations and repeated findings of mutations in familial Alzheimer disease.

Authors:  Ulrich Finckh; Christian Kuschel; Maria Anagnostouli; Efstratios Patsouris; George V Pantes; Stylianos Gatzonis; Elisabeth Kapaki; Panagiota Davaki; Katrin Lamszus; Dimitrios Stavrou; Andreas Gal
Journal:  Neurogenetics       Date:  2005-03-18       Impact factor: 2.660

3.  An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration.

Authors:  Sabrina M Lehmann; Christina Krüger; Boyoun Park; Katja Derkow; Karen Rosenberger; Jan Baumgart; Thorsten Trimbuch; Gina Eom; Michael Hinz; David Kaul; Piet Habbel; Roland Kälin; Eleonora Franzoni; Agnieszka Rybak; Duong Nguyen; Rüdiger Veh; Olaf Ninnemann; Oliver Peters; Robert Nitsch; Frank L Heppner; Douglas Golenbock; Eckart Schott; Hidde L Ploegh; F Gregory Wulczyn; Seija Lehnardt
Journal:  Nat Neurosci       Date:  2012-06       Impact factor: 24.884

Review 4.  The biomarker and therapeutic potential of miRNA in Alzheimer's disease.

Authors:  Lynn M Bekris; James B Leverenz
Journal:  Neurodegener Dis Manag       Date:  2015

5.  Profiling of circulating microRNAs in children with recent onset of type 1 diabetes.

Authors:  Suheda Erener; Ashish Marwaha; Rusung Tan; Constadina Panagiotopoulos; Timothy J Kieffer
Journal:  JCI Insight       Date:  2017-02-23

6.  MiR-30a-5p Suppresses Tumor Metastasis of Human Colorectal Cancer by Targeting ITGB3.

Authors:  Wei Wei; Yang Yang; Jian Cai; Kai Cui; Rong Xian Li; Huan Wang; Xiujuan Shang; Dong Wei
Journal:  Cell Physiol Biochem       Date:  2016-08-31

7.  Genome-wide serum microRNA expression profiling identifies serum biomarkers for Alzheimer's disease.

Authors:  Lin Tan; Jin-Tai Yu; Meng-Shan Tan; Qiu-Yan Liu; Hui-Fu Wang; Wei Zhang; Teng Jiang; Lan Tan
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

Review 8.  Molecular Basis of Familial and Sporadic Alzheimer's Disease.

Authors:  Jolanta Dorszewska; Michal Prendecki; Anna Oczkowska; Mateusz Dezor; Wojciech Kozubski
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

9.  Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer's and Parkinson's diseases correlate with disease status and features of pathology.

Authors:  Kasandra Burgos; Ivana Malenica; Raghu Metpally; Amanda Courtright; Benjamin Rakela; Thomas Beach; Holly Shill; Charles Adler; Marwan Sabbagh; Stephen Villa; Waibhav Tembe; David Craig; Kendall Van Keuren-Jensen
Journal:  PLoS One       Date:  2014-05-05       Impact factor: 3.240

10.  A Presenilin/Notch1 pathway regulated by miR-375, miR-30a, and miR-34a mediates glucotoxicity induced-pancreatic beta cell apoptosis.

Authors:  Yating Li; Tao Zhang; Yuncai Zhou; Yi Sun; Yue Cao; Xiaoai Chang; Yunxia Zhu; Xiao Han
Journal:  Sci Rep       Date:  2016-11-02       Impact factor: 4.379

View more
  5 in total

1.  Sirtuins: Developing Innovative Treatments for Aged-Related Memory Loss and Alzheimer's Disease.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2018       Impact factor: 1.990

2.  Differentially Expressed miRNAs in Age-Related Neurodegenerative Diseases: A Meta-Analysis.

Authors:  Ocana Noronha; Lucia Mesarosovo; Jasper J Anink; Anand Iyer; Eleonora Aronica; James D Mills
Journal:  Genes (Basel)       Date:  2022-06-09       Impact factor: 4.141

3.  Gene biomarker discovery at different stages of Alzheimer using gene co-expression network approach.

Authors:  Negar Sadat Soleimani Zakeri; Saeid Pashazadeh; Habib MotieGhader
Journal:  Sci Rep       Date:  2020-07-22       Impact factor: 4.379

Review 4.  Gene mutations associated with early onset familial Alzheimer's disease in China: An overview and current status.

Authors:  Qi Qin; Yunsi Yin; Yan Wang; Yuanyuan Lu; Yi Tang; Jianping Jia
Journal:  Mol Genet Genomic Med       Date:  2020-08-06       Impact factor: 2.183

5.  Epigenomics and Lipidomics Integration in Alzheimer Disease: Pathways Involved in Early Stages.

Authors:  Carmen Peña-Bautista; Lourdes Álvarez-Sánchez; Antonio José Cañada-Martínez; Miguel Baquero; Consuelo Cháfer-Pericás
Journal:  Biomedicines       Date:  2021-12-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.